EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Chimeric antigen receptor therapies: Development, design, and implementation

Madeline J Lee, Frank Cichocki, Jeffrey S Miller

Journal of Allergy and Clinical Immunology · 2025

DOI: 10.1016/j.jaci.2025.04.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Madeline J Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Minnesota, Minneapolis, Minn. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Immunotherapy, Adoptive, Killer Cells, Natural, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NIH NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) T and natural killer (NK) cell therapies represent a promising strategy for the treatment of cancers and other chronic diseases. Engineered CAR constructs endow immune cells with the ability to target desired antigens with high specificity, allowing for directed responses to antigen-expressing cells. CAR T and NK cells have shown marked success in the treatment of hematologic malignancies, although there remains a large population of patients with disease that fails to respond to CAR therapies, and their efficacy in solid tumors is still limited. In this review, we provide a broad overview of the development, design, and implementation of CAR therapies from bench to bedside. We discuss the building blocks of CAR constructs and how these can be manipulated to optimize CAR functionality, review the possible sources of T and NK cells for CAR therapies, and examine the limitations of both CAR T and CAR NK cells. Finally, we discuss recent breakthroughs in the CAR field and consider how these advances may affect the success of CAR therapies in the years to come.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenImmunotherapy, AdoptiveKiller Cells, NaturalNeoplasmsT-LymphocytesReceptors, Antigen, T-CellHumansAnimals

Stichwörter der Autor:innen

CAR NK cellsCAR T cellscancerimmunotherapy

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Medicine, University of Minnesota, Minneapolis, Minn.
  • Department of Medicine, University of Minnesota, Minneapolis, Minn. Electronic address: mille011@umn.edu.

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • NIH NCI
  • NIH

Zitieren

APA

Lee, M. J., Cichocki, F., & Miller, J. S. (2025). Chimeric antigen receptor therapies: Development, design, and implementation. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.04.005

Vancouver

Lee MJ, Cichocki F, Miller JS. Chimeric antigen receptor therapies: Development, design, and implementation. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2025.04.005

BibTeX
@article{Lee2025,
  author = {Lee, Madeline J and Cichocki, Frank and Miller, Jeffrey S},
  title = {Chimeric antigen receptor therapies: Development, design, and implementation},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2025},
  doi = {10.1016/j.jaci.2025.04.005}
}
Kostenlos starten →